NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1033226006 MD
Verify on CMS → Zhiyong Li, MD
Hematology & Oncology Physician in Garland, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 187 beneficiaries · Hematology & Oncology Physician avg: 885
MIPS score
9.3/100
▼ 74 pts below national avg 83.5 · Penalty band
Industry payments
$2.3K
102 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Zhiyong Li, MD reported a CMS MIPS final score of 9.3/100 - below the 83.5 national average - and filed 1,312 Medicare Part D claims in 2024.
- 9.3/100
- MIPS score · -74 vs avg
- 1K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥2nd
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Zhiyong Li, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1033226006), first enumerated 08/24/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,312 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 9.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$2.3K in reported industry payments (102 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Zhiyong Li, MD's individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1033226006 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1033226006
- ENUM-LEGACY 2006
- TAX-MID 12K Hematology &
- MIPS-LOW 9.3/100
- RX-MID 1,312
- BOOK-LIGHT 637 in Texas
- PHOTO-FINISH Catherine Burbage · ±0.4
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Jeffrey Cronk · …
Jeffrey Cronk
7.3 MIPS pts
- Mark Pajeau · near
Mark Pajeau
8.3 MIPS pts
- Catherine Burbag…
Catherine Burbage
8.9 MIPS pts
- Li · this provider
Li · this provider
9.3 MIPS pts
- Mahinur Khan · h…
Mahinur Khan
10.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Zhiyong Li, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
9 ≥ 2nd percentile 2% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Zhiyong Li, MD sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Zhiyong Li, MD writes more Part D claims than 75% of them and scores higher on MIPS quality than 1% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Zhiyong Li, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Zhiyong Li, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Zhiyong Li, MD?
Below national averagePrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,312 48% vs specialty avg
MIPS final score
9.3/100 74.2 pts vs avg
Specialty distribution in Texas
How Hematology & Oncology Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Zhiyong Li, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 9.3/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1033226006 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/24/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
9.2871
Final Score
Measured-score avg: 83.5
0
Quality
30.957
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Zhiyong Li, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.3K
Largest payer
PFIZER INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Zhiyong Li, MD. To verify Zhiyong Li, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,312
Total Claims
$2.6M
Total Drug Cost
187
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,133.333
- Total Day Supply
- 60,553
- Generic Drug Cost
- $599K
- Opioid Claims
- 123 (9.4% rate)
- Antibiotic Claims
- 62
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 2.51
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 14, 65-74: 84, 75-84: 69, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Zhiyong Li, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Eliquis
Eliquis
93 claims
- Warfarin Sodium
Warfarin Sodium
74 claims
- Anastrozole
Anastrozole
71 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
52 claims
- Hydroxyurea
Hydroxyurea
51 claims
- Alprazolam
Alprazolam
48 claims
- Gabapentin
Gabapentin
48 claims
- Amlodipine Besylate
Amlodipine Besylate
39 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 93 |
| Warfarin Sodium | 74 |
| Anastrozole | 71 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 52 |
| Hydroxyurea | 51 |
| Alprazolam | 48 |
| Gabapentin | 48 |
| Amlodipine Besylate | 39 |
| Dexamethasone | 35 |
| Ondansetron Hcl | 33 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Zhiyong Li, MD fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Zhiyong Li, MD's 1,312 claims are above the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Li, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (9.3 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Li.
One of 637 Hematology & Oncology Physician providers enrolled in Texas, 5 are shown here.
Dr. Elham Abbasi-Hafshejani
M.D.
The Woodlands, TX
Dr. Muhammad Abid
M.D.
Lubbock, TX
Dr. Ambrose Aboud
MD
El Paso, TX
Dr. Joel Abramowitz
M.D., PHD
Houston, TX
Dr. John Adams
DO
Arlington, TX
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Zhiyong Li, MD's specialty? ▼
Zhiyong Li, MD specializes in Hematology & Oncology Physician and practices in Garland, Texas. Credentials: MD.
How much does Zhiyong Li, MD prescribe under Medicare Part D? ▼
In 2024, Zhiyong Li, MD wrote 1,312 Medicare Part D claims totaling $2.6M in drug costs for 187 beneficiaries.
What is Zhiyong Li, MD's Medicare quality score? ▼
Zhiyong Li, MD has a CMS MIPS Final Score of 9.3/100 (Quality: 0, Cost: 31). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Zhiyong Li, MD located? ▼
Zhiyong Li, MD is located at 315 N SHILOH RD, Garland, TX, 75042. Phone: (972) 487-8866.
What is Zhiyong Li, MD's NPI number? ▼
Zhiyong Li, MD's National Provider Identifier (NPI) is 1033226006, issued on 08/24/2006.
Does Zhiyong Li, MD prescribe opioids? ▼
Yes, Zhiyong Li, MD had 123 opioid claims in 2024 with an opioid prescribing rate of 9.4%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Zhiyong Li, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Zhiyong Li, MD's most frequently prescribed drugs include Eliquis, Warfarin Sodium, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Zhiyong Li, MD accept Medicare? ▼
Zhiyong Li, MD appears in CMS Medicare data with 1,312 Part D claims and 187 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Zhiyong Li, MD's credentials? ▼
Zhiyong Li, MD's NPI is 1033226006 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.